| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 32.7 | 23.3 | 25.2 |
| Other income | 0.7 | 0.6 | 1.4 |
| Total income | 33.4 | 23.9 | 26.6 |
| Profit before exceptional items & tax | -3.0 | 0.1 | -6.2 |
| Exceptional items | 0.0 | 0.0 | -2.9 |
| Profit before tax | -3.0 | 0.1 | -9.0 |
| Net profit | -3.6 | 0.8 | -7.0 |
| Operating margin | -9.0% | 0.4% | -33.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +29.80% |
|---|
NSE results filing, NSE: JHS. Figures extracted from the filing.
JHS Svendgaard Laboratories Ltd: key numbers
- Share price
- ₹8.43
- Market cap
- ₹72.16 Cr
- Revenue (annual)
- ₹101.7 Cr
- Net profit (annual)
- ₹-1.92 Cr
- P/E (TTM)
- -38.2×Sector 43.4×
- Promoter holding
- 33.85%+0.00% QoQ
- FII holding
- 3.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JHS Svendgaard Laboratories Ltd
All →JHS Svendgaard Laboratories Annual General Meeting
JHS Svendgaard Laboratories held its 22nd Annual General Meeting on September 26, 2026, transacting business related to financial statements and director appointment.
JHS Svendgaard Laboratories Other Announcement
JHS Svendgaard Labs filed a Reg 36(1)(b) letter sending web-links and QR codes for its 2025-26 Annual Report to unregistered shareholders. No transaction, board decision, or business event is involved.
JHS Svendgaard Laboratories Annual General Meeting
JHS Svendgaard Laboratories Ltd will hold its 22nd Annual General Meeting on September 26, 2026. Shareholders will consider financial statements and director re-appointment.
JHS Svendgaard Laboratories Annual Report
JHS Svendgaard Laboratories Limited has filed its Integrated Annual Report for the Financial Year 2025-26, including notice for the 22nd Annual General Meeting.
JHS Svendgaard Laboratories Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 0.0% YoY
JHS Svendgaard Laboratories Ltd reported revenue from operations of ₹30.4 Cr (+29.4% YoY) and net profit of ₹1.1 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +0.0% YoY